Dergiler / European Journal of Rheumatology / 2016 / Cilt: 3 - Sayı: 2

Evaluating disease activity in patients with ankylosing spondylitis and rheumatoid arthritis using 99mtc- glucosamine

Sayfa
65–72
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

With respect to RA, 99mTc-glucosamine was a viable alternative to 99mTc-labeled methylene diphosphonate nuclear bone scans for imaging inflamed joints and had the added advantage of demonstrating a significant clinical correlation between disease activity and scan findings

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: To evaluate the clinical utility of a novel radiotracer, 99mTc-glucosamine, in assessing disease activity of both rheumatoid arthritis (RA) and ankylosing spondylitis (AS).
📊
Temel Bulgular & Veri:Material and Methods: Twenty-five patients with RA (nine males and 16 females) and 12 patients with AS (all male) at various stages of disease were recruited for the study.
💡
Sonuç & Katkı:With respect to RA, 99mTc-glucosamine was a viable alternative to 99mTc-labeled methylene diphosphonate nuclear bone scans for imaging inflamed joints and had the added advantage of demonstrating a significant clinical correlation between disease activity and scan findings
🔬Tür:Laboratuvar & Saha Deneyi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: To evaluate the clinical utility of a novel radiotracer, 99mTc-glucosamine, in assessing disease activity of both rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Material and Methods: Twenty-five patients with RA (nine males and 16 females) and 12 patients with AS (all male) at various stages of disease were recruited for the study. A clinical history and examination was performed, followed by the measurement of hematological, biochemical, and autoimmune serological parameters to assess disease activity. 99mTc-glucosamine was intravenously administered and scans were compared with other imaging modalities, including plain X-ray, magnetic resonance imaging (MRI), and bone scans.Results: In patients with AS, 99mTc-glucosamine scans were more capable of identifying active disease and differentiating between inflammatory and non-inflammatory causes. In patients with RA, 99mTc-glucosamine accumulated at all known sites of disease involvement. Uptake was most pronounced in patients with active untreated disease. The relative tracer activity in the involved joints increased with time compared with that in the adjoining soft tissue, liver, and cardiac blood pool. Using Spearman's correlation coefficient, there was a positive correlation among glucosamine scan scores, C-reactive protein (p=0.048), and clinical assessment (p=0.003), which was not noted with bone scans.Conclusion: The radiotracer was well tolerated by all patients, with no adverse reactions. 99mTc-glucosamine imaging could detect spinal inflammation in AS. With respect to RA, 99mTc-glucosamine was a viable alternative to 99mTc-labeled methylene diphosphonate nuclear bone scans for imaging inflamed joints and had the added advantage of demonstrating a significant clinical correlation between disease activity and scan findings

🔖

Bu Makaleye Atıf Yap

MANOLİOS, N., ALİ, M., CAMDEN, B., AFLAKY, E., PAVİC, K., MARKEWYCZ, A., ANGELİDES, S., COSTA, R. D. (2022). Evaluating disease activity in patients with ankylosing spondylitis and rheumatoid arthritis using 99mtc- glucosamine. European Journal of Rheumatology, Cilt: 3 - Sayı: 2, 65–72. https://ajindex.com/articles/511777

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Beckers C, Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 2004; 45: 956-64.
  2. Goerres GW, Forster A, Uebelhart D, Seifert B, Treyer V, Michel B, et al. F-18 FDG whole-body PET for the assessment of disease activity in pa- tients with rheumatoid arthritis. Clin Nucl Med 2006; 31: 386-90.[CrossRef] Walter MA, Melzer RA, Schindler C, Müller-Brand J, Tyndall A, Nitzsche EU. The value of [18F]FDG- PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005; 32: 674-81. [CrossRef] Yang DJ, Kim C, Schechter NR, Azhdarinia A, Yu DF, Oh CS, et al. Imaging with 99mTc-ECDG Tar- geted at the Multifunctional Glucose Transport System: Feasibility Study with Rodents. Radiolo- gy 2003; 226: 465-73. [CrossRef] Yang D, Yukihiro M, Yu D, Ito M, Oh C, Kohanim S, et al. Assessment of therapeutic tumor re- sponse using 99mTc-Ethylenedicysteine-Glu- cosamine. Cancer Biother Radiopharm 2004; 19: 443-56. [CrossRef] Zhang Y, Bryant J, Kong F, Yu D, Mendez R, Kim E, et al. Molecular imaging of mesothelioma with 99mTc-ECG and 68Ga-ECG. J Biomed Biotech- nol 2012; 2012: 232863. [CrossRef] Schechter N, Erwin W, Yang D, Kim E, Munden R, Forster K, et al. Radiation dosimetry and bio- distribution of 99mTc-ethylene dicysteine-de- oxyglucose in patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 2009; 36: 1583-91. [CrossRef] Kumar V, Ali M, Angelides S, Manolios N. Synthe- sis and characterisation of 99mTc-Glucosamine and 99mTc-His-CP and evaluation of their utili- ty in imaging inflammatory arthritis. ANZ Nucl Med 2007; 38: 1-13.
  3. Shah S, Jawed H, Awan S, Anjum S, Simjee S. The anti-arthritic and immunomodulatory ef- fects of NHAG:A novel glucosamine analogue in adjuvant -induced arthritis. Biomed Res Int 2013; 2013: 487610. [CrossRef] Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, et al. The american rheu- matism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheum 1988; 31: 315-24. [CrossRef] Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of Spondy- loArthritis international Society (ASAS). Ann Rheum Dis 2009; 68: 784-8. [CrossRef] Chang L-T. A method for attenuatio